These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 8663912)
1. Synthesis and preliminary in vitro screening of lipophilic alpha, gamma-bis(amides) as potential prodrugs of methotrexate. Pignatello R; Sorrenti V; Spampinato G; Pecora T; Panico A; Di Giacomo C; Fresta M; Vanella A; Puglisi G Anticancer Drug Des; 1996 Apr; 11(3):253-64. PubMed ID: 8663912 [TBL] [Abstract][Full Text] [Related]
2. Lipophilic conjugates of methotrexate with short-chain alkylamino acids as DHFR inhibitors. Synthesis, biological evaluation, and molecular modeling. Pignatello R; Guccione S; Forte S; Di Giacomo C; Sorrenti V; Vicari L; Uccello Barretta G; Balzano F; Puglisi G Bioorg Med Chem; 2004 Jun; 12(11):2951-64. PubMed ID: 15142554 [TBL] [Abstract][Full Text] [Related]
3. Lipophilic methotrexate conjugates with antitumor activity. Pignatello R; Spampinato G; Sorrenti V; Di Giacomo C; Vicari L; McGuire JJ; Russell CA; Puglisi G; Toth I Eur J Pharm Sci; 2000 May; 10(3):237-45. PubMed ID: 10767601 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and in vitro antifolate activity of rotationally restricted aminopterin and methotrexate analogues. Rosowsky A; Forsch RA; Wright JE J Med Chem; 2004 Dec; 47(27):6958-63. PubMed ID: 15615544 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological activities of tricyclic conformationally restricted tetrahydropyrido annulated furo[2,3-d]pyrimidines as inhibitors of dihydrofolate reductases. Gangjee A; Elzein E; Queener SF; McGuire JJ J Med Chem; 1998 Apr; 41(9):1409-16. PubMed ID: 9554874 [TBL] [Abstract][Full Text] [Related]
6. Antibody-directed enzyme prodrug therapy with the T268G mutant of human carboxypeptidase A1: in vitro and in vivo studies with prodrugs of methotrexate and the thymidylate synthase inhibitors GW1031 and GW1843. Wolfe LA; Mullin RJ; Laethem R; Blumenkopf TA; Cory M; Miller JF; Keith BR; Humphreys J; Smith GK Bioconjug Chem; 1999; 10(1):38-48. PubMed ID: 9893962 [TBL] [Abstract][Full Text] [Related]
7. Synthesis, dihydrofolate reductase inhibition, antitumor testing, and molecular modeling study of some new 4(3H)-quinazolinone analogs. Al-Rashood ST; Aboldahab IA; Nagi MN; Abouzeid LA; Abdel-Aziz AA; Abdel-Hamide SG; Youssef KM; Al-Obaid AM; El-Subbagh HI Bioorg Med Chem; 2006 Dec; 14(24):8608-21. PubMed ID: 16971132 [TBL] [Abstract][Full Text] [Related]
8. Ex vivo activity of methotrexate versus novel antifolate inhibitors of dihydrofolate reductase and thymidylate synthase against childhood leukemia cells. Mauritz R; Bekkenk MW; Rots MG; Pieters R; Mini E; van Zantwijk CH; Veerman AJ; Peters GJ; Jansen G Clin Cancer Res; 1998 Oct; 4(10):2399-410. PubMed ID: 9796971 [TBL] [Abstract][Full Text] [Related]
9. Impact of polyglutamation on sensitivity to raltitrexed and methotrexate in relation to drug-induced inhibition of de novo thymidylate and purine biosynthesis in CCRF-CEM cell lines. Barnes MJ; Estlin EJ; Taylor GA; Aherne GW; Hardcastle A; McGuire JJ; Calvete JA; Lunec J; Pearson AD; Newell DR Clin Cancer Res; 1999 Sep; 5(9):2548-58. PubMed ID: 10499632 [TBL] [Abstract][Full Text] [Related]
11. Analogues of N alpha-(4-amino-4-deoxypteroyl)-N delta-hemiphthaloyl-L-ornithine (PT523) modified in the side chain: synthesis and biological evaluation. Rosowsky A; Vaidya CM; Bader H; Wright JE; Teicher BA J Med Chem; 1997 Jan; 40(3):286-99. PubMed ID: 9022795 [TBL] [Abstract][Full Text] [Related]
12. Resistance mechanisms to methotrexate in tumors. Bertino JR; Göker E; Gorlick R; Li WW; Banerjee D Stem Cells; 1996 Jan; 14(1):5-9. PubMed ID: 8820944 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological activity of folic acid and methotrexate analogues containing L-threo-(2S,4S)-4-fluoroglutamic acid and DL-3,3-difluoroglutamic acid. Hart BP; Haile WH; Licato NJ; Bolanowska WE; McGuire JJ; Coward JK J Med Chem; 1996 Jan; 39(1):56-65. PubMed ID: 8568827 [TBL] [Abstract][Full Text] [Related]
14. Thymidylate synthase as a target for growth inhibition in methotrexate-sensitive and -resistant human head and neck cancer and leukemia cell lines. McGuire JJ; Magee KJ; Russell CA; Canestrari JM Oncol Res; 1997; 9(3):139-47. PubMed ID: 9220499 [TBL] [Abstract][Full Text] [Related]